Reimagining the Future of Genetic Testing

Revolutionizing the preimplantation genetic testing laboratory allowing for greater access, accuracy, and clinical impact

Transforming Genetic Testing with Experience and Innovation

At NOVA Genomics, we are reimagining preimplantation genetic testing (PGT). Founded by industry veterans Cynthia Hudson and Dr. Gary Harton, NOVA brings together cutting-edge technology, compassionate counseling, and a new standard of care to help patients and IVF providers navigate the complexities of genetic testing.

Our team is developing an advanced platform that will serve as the foundation for our contribution to the future of reproductive genetic testing.

UNDERSTANDING PREIMPLANTATION GENETIC TESTING

PGT is a diagnostic screening tool used alongside in vitro fertilization (IVF) and may improve the chances of a successful pregnancy, reduce the chance of miscarriage and lead to quicker successes. (need to reference this one)

At NOVA Genomics, we analyze embryos created during IVF to check for chromosomal abnormalities, such as extra or missing chromosomes, as well as single-gene disorders and structural chromosomal rearrangements that can lead to inherited genetic conditions.

PGT is offered in three key forms: PGT-A, PGT-M, and PGT-SR, each designed to address different genetic concerns and support better outcomes in fertility treatment.

PGT-A

Preimplantation Genetic Testing for Aneuploidy (PGT-A) is a genetic test used during IVF to screen embryos for chromosomal abnormalities, a condition know as aneuploidy, improving the chances of a successful pregnancy and reducing the risk of miscarriage.

PGT-SR

Preimplantation Genetic Testing for Structural Rearrangements (PGT-SR) helps identify embryos with a normal balance of chromosomes, increasing the chances of a healthy pregnancy and reducing the risk of passing on serious genetic conditions.

PGT-M

Preimplantation Genetic Testing for Monogenic Disorders (PGT-M) is a specialized form of genome sequencing to screen embryos for single-gene disorders, allowing fertility specialists to select embryos with less risk of inheriting the disorder.

nova genomics: A Modern Approach
to Preimplantation Genetic Testing

NOVA Genomics was founded by two pioneers in the IVF industry. Cynthia Hudson and Dr. Gary Harton, who bring over 50 years of combined experience in Embryology and Preimplantation Genetic Testing (PGT). After decades of work, they recognized critical gaps in the field, including outdated lab technologies, growing concerns about quality and compliance, and ongoing debates over the clinical value of PGT.

Their response was to build a next-level PGT lab from the ground up, focused on expanding access to advanced genetic services, focusing on families in need of PTG-SR and PGT-M testing for inherited conditions.

our mission

Mission statement to go here.

Driven by this mission, NOVA Genomics is transforming the PGT experience through:

leadership
in education

We are committed to educating our customers and the broader community about the science and benefits of PGT. By promoting awareness and understanding, we support informed decision-making throughout the IVF and genetic screening process.

excellence in
genetic counseling

We offer best-in-class genetic counseling services to support patients throughout their journey. With flexible communication options, including live consultations, patients can review their PGT results with a certified genetic counselor.

strategic
partnerships

Led by an industry-leading management team, we are forging strategic partnerships with leading reagent and software providers to guarantee that our patients and clinical partners have access to the most advanced, reliable, and effective tools in reproductive genetics.

innovation
technology platform

We are developing a new and more effective PGT platform that prioritizes high-quality genetic insights over marketing. Our focus is on delivering accurate results that put patient needs and scientific integrity at the forefront of fertility care.

Meet the Experts Behind NOVA Genomics

founders

Cynthia Hudson

Chief Executive Officer

Cynthia has over 20 years experience as an embryologist, entrepreneur, and product specialist.

Gary Harton PhD

Chief Scientific Officer

Gary is a laboratory professional with an extensive 35-year experience covering embryology/andrology, molecular and classic cytogenetics, next-generation sequencing, and clinical genetics.

clinical team

Harvey Stern MD, PhD (FAACP)

Medical Director

Harvey is an experienced pediatrician, clinical geneticist, and PGT expert.

Mary Sands, CGC

Director of Clinical Services

Mary has over 20 training and research years specializing in prenatal, NIPT, and PGT in top clinical settings.

laboratory team

Brian Mariani PhD

Director of Clinical Services

Brian has extensive training and research experience in molecular biology at Stanford, Harvard, and Thomas Jefferson Hospital

Khoa Tran

Lab Team Lead SNV

Khoa…

Veronica Novik PhD

Lab Team Lead CNV

Veronica…

RESOURCES

Connect with our team of experts to learn more about PGT and IVF support